×

1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as AHR activators

  • US 8,962,598 B2
  • Filed: 10/11/2011
  • Issued: 02/24/2015
  • Est. Priority Date: 10/14/2010
  • Status: Active Grant
First Claim
Patent Images

1. A compound of the general formula I or a pharmaceutically acceptable salt thereof:

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×